z-logo
open-access-imgOpen Access
Research Domain Criteria: Cutting Edge Neuroscience or Galen’s Humors Revisited?
Author(s) -
Colin J.D. Ross,
Russell L. Margolis
Publication year - 2018
Publication title -
complex psychiatry
Language(s) - English
Resource type - Journals
eISSN - 2673-3005
pISSN - 2673-298X
DOI - 10.1159/000493685
Subject(s) - research domain criteria , psychology , schizophrenia (object oriented programming) , context (archaeology) , mental health , cognitive neuroscience , neuroimaging , neuropsychology , neuroscience , cognitive science , psychiatry , cognition , paleontology , biology
The Research Domain Criteria (RDoC) scheme has guided the research agenda of the National Institute of Mental Health for the past decade. The essence of RDoC is its dimensional conception of mental illness, with the assumption that psychopathology is a manifestation of extremes along axes of neuropsychological variation. Research, it follows, should emphasize normal neuropsychological function and its associated neurocircuitry. We argue that RDoC, dressed in terms of modern neurobiology, is in fact a return to the humoral theory of Galen, a dimensional approach in which physical and mental health requires a balance of the four basic bodily humors (blood, black bile, yellow bile, and phlegm). The RDoC/Galenic approach may be useful in understanding those conditions best understood as extremes along a continuum, such as personality disorders. However, we contend that for the most severe psychiatric disorders - categorically defined diseases such as schizophrenia, bipolar disorder, and autism - RDoC's Galenic dimensionalism is a retreat from the biomedical approach that seeks to find rational therapeutic targets by identifying etiologic factors and pathogenic pathways. Abandoning this medical model now, in the context of remarkable advances in genetics, neuroimaging, and neuroscience, is a major setback for the advancement of scientific psychiatry.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here